Piper Sandler has upgraded Oscar Health Inc (OSCR) to Overweight from Neutral, signaling a more optimistic outlook on the company's future prospects. This decision, made on November 25, 2025, comes as Oscar Health's stock trades at $18.16.
Oscar Health, headquartered in New York City, operates in the insurance industry and employs approximately 2,400 full-time staff. The company, which went public on March 3, 2021, offers health plans through its technology platform, +Oscar, primarily targeting the individual market. This market consists of policies purchased by individuals and families through health insurance marketplaces established by the Affordable Care Act (ACA) and other state-operated platforms.
The upgrade reflects improved analyst sentiment, suggesting enhanced fundamentals or better-than-expected performance. The current market capitalization of Oscar Health stands at $3.6 billion, with a trailing twelve months earnings per share (EPS) of -1.14. Upcoming earnings reports are anticipated, with EPS estimates of $0.01 on August 4, 2026, and $0.56 on May 5, 2026.
Analyst ratings, while informative, are based on research and financial models that may not always align with actual outcomes. As such, they should be considered alongside other factors, including company fundamentals and industry trends, when making investment decisions. The analyst consensus for Oscar Health remains a Sell, with recent ratings indicating a mix of perspectives among analysts.
This update provides insight into the evolving view of Oscar Health's potential, a company that continues to navigate the complex landscape of health insurance.